FDA Brief

Warning letters Food

FDA warning letter to

Kemal Balikcilik Ihracat

High riskIssued Jan 12, 2022Posted Mar 8, 2022Center for Food Safety and Applied Nutrition (CFSAN)

FDA found Turkish seafood processor Kemal Balikcilik’s plans lacked histamine controls for tuna/anchovy and drug-residue controls for farmed fish.

What happened

FDA conducted a remote assessment of the seafood processing facility from September 7 to September 14, 2021, instead of an on-site inspection because of COVID-19 travel restrictions. FDA found the firm’s HACCP (seafood safety) plans did not list receiving as a critical control point to control fish-farming drug residues for seabass, seabream, salmon, trout, and anchovy, and did not list receiving, processing, and refrigerated storage controls for scombrotoxin (histamine) formation in tuna and anchovy. FDA also said the tuna plans did not make clear whether the fish were wild or farmed and that allergen labeling hazards were not identified as critical control points in each plan.

What FDA found

  1. The HACCP plans for seabass, seabream, salmon, trout, and anchovy did not list receiving as a critical control point to control fish-farming drug residues.

    21 CFR 123.6(a) and (c)(2)
  2. The HACCP plans for tuna and anchovy did not list receiving, processing, and refrigerated storage as critical control points to control scombrotoxin (histamine) formation.

    21 CFR 123.6(a) and (c)(2)
  3. The tuna/anchovy processing limit did not ensure histamine was no more than the stated limit in each lot of scombrotoxin-forming fish.

    21 CFR 123.6(a) and (c)(2)
  4. The tuna HACCP plans did not clarify whether tuna were wild, farmed, or both, and did not identify fish-farming drugs as a hazard.

    21 CFR Part 123
  5. The HACCP plans did not identify undeclared allergens as a hazard at labeling critical control points to ensure the right label is on the right product.

    21 CFR Part 123

What FDA wants

FDA tells the company to respond in writing within 15 working days, outline the specific corrective steps, and include a revised HACCP plan plus five consecutive days of completed monitoring records for five production date codes.

Who should pay attention

  • US importers of Turkish seafood
  • brands buying tuna, seabass, seabream, salmon, trout, or anchovy from this processor
  • QA teams managing foreign supplier verification

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ocean Pride Seafood, Inc.

    FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.

    High risk
  2. Star Ocean Wholesale Foods, Inc.

    FDA warns Star Ocean Wholesale Foods over missing checks for imported fermented fish sauce.

    High risk
  3. South Asian Food Inc.

    South Asian Food Inc. lacked seafood HACCP import verification and pest controls for imported dried seafood.

    High risk
  4. AF Import & Wholesale Co

    FDA warned Houston seafood importer AF Import & Wholesale for missing written verification that its imported fish was processed safely.

    High risk